60 DEGREES PHARMACEUTICALS, INC. - 8-K Filing
60 Degrees Pharmaceuticals updated its investor presentation on September 8, 2026 to highlight ARAKODA's potential expansion into babesiosis and financial progress. (Items: 7.01 Regulation FD Disclosure On September 8, 2026, the Company updated its investor presentation, which it intends to use from time to time in me, 9.01 Financial Statements and Exhibits (a) Exhibits Number Description 99)
Tickers: $SXTP